2018 Events

View upcoming events

American Academy of Ophthalmology Annual Meeting 2018
Randomized, Prospective, Double-Masked Controlled Phase 2b Trial on the Safety & Efficacy of Risuteganib (Luminate) for DME

Presented by Peter K. Kaiser, MD
October 29, 2018
McCormick Place, Chicago

OIS@AAO 2018
Risuteganib for the Treatment of DME

Presented by Vicken Karageozian, MD, President & CEO
October 25, 2018
Marriott Marquis Chicago

18th EURETINA Congress
Randomized, Prospective, Double-Masked, Controlled Phase 2b Trial to Evaluate the Safety & Efficacy of ALG-1001 (Luminate®) in Diabetic Macular Edema (DME)

Presented by Pravin Dugel, MD
September 20, 2018
The Reed Messe Center, Vienna, Austria

American Society of Retina Specialists (ASRS) Annual Meeting 2018
Randomized, Prospective, Double-Masked, Controlled Phase 2b Trial to Evaluate the Safety & Efficacy of ALG-1001 (Luminate®) in Diabetic Macular Edema

Presented by Peter K. Kaiser, MD
July 24, 2018
Vancouver Convention Center, Vancouver, Canada

OIS RETINA 2018
Risuteganib (Luminate®) for the Treatment of DME

Presented by Vicken Karageozian, MD, President & CMO, Allegro Ophthalmics
July 20, 2018
Four Seasons, Vancouver, Canada

OCTANe Ophthalmology Technology Summit
Risuteganib (Luminate®) Potential Paradigm Shift for Broad Spectrum Treatment of Diabetic Macular Edema

Presented by Vicken Karageozian, MD, President & CMO, Allegro Ophthalmics
June 29, 2018
Newport Beach, CA

2018 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Effects of Anti-VEGF and ALG-1001 on Human Retinal Cells In Vitro

Special Interest Group: Managing Patients with Diabetic Macular Edema, Diabetic Retinopathy, Neovascular and Non-Neovascular AMD, and Retinal Vein Occlusion: How to Best Utillize the Latest Data from Clinical Trials

Faculty includes Peter Campochiaro, Judy Kim, Robert Avery, David Boyer, Diana Do, and Quan Dong Nguyen
April 30, 2018
Honolulu, Hawaii

Randomized, Prospective, Double-Masked, Controlled Phase 2b Trial to Evaluate the Safety and Efficacy of ALG-1001 (Luminate) in Diabetic Macular Edema

Presented by Hugo Quiroz-Mercado, MD
April 30, 2018
Honolulu, Hawaii

Presented by Cristina Kenney, MD, PhD
April 29, 2018
Honolulu, Hawaii

ISOPT Clinical 2018
Randomized, Prospective, Double-Masked, Controlled Phase 2b Trial to Evaluate the Safety and Efficacy of ALG-1001 (Luminate) in DME

Presented by Baruch D. Kuppermann, MD, PhD
March 1, 2018
Tel-Aviv, Israel

Angiogenesis, Exudation, and Degeneration 2018
Integrin Antagonism and Diabetic Macular Edema

Presented by Peter K. Kaiser, MD
February 10, 2018
Miami, FL

Hawaiian Eye & Retina 2018
Prospective, Double-Masked, Placebo-Controlled Phase 2b Trial on the Safety and Efficacy of ALG-1001 (Luminate) in DME

Presented by Peter K. Kaiser, MD
January 17, 2018
Maui, Hawaii

View 2017 Events